Company / Current Liabilities
GeneDx Holdings Corp. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$108.9M
FY2025
5-year range
$54.8M / $144.3M
FY2021-FY2025
Trend
+98.7%
vs FY2024
Sector context
#125 of 165
Health Care
What the data says
GeneDx Holdings Corp.'s current liabilities of $109M is lower than 76% of companies in the Health Care sector (FY2025). Current Liabilities returned to growth in FY2025 after 2 years of decline, reaching $109M.
Based on SEC 10-K filings.
$109M in FY2025 with a 5-year CAGR of +8.2%.
Increased from $59M to $109M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -9.0%
- 5-Year CAGR
- +8.2%
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 165This company $108.9M Sector average $4.4B
▼
-97.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +8.2%, indicating consistent growth.
- In FY2025, current liabilities increased 98.7% year-over-year.
- Ranks #125 out of 165 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.67 (distress zone, below 1.8 threshold)
- Negative profit margin: -17.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $108.9M | +98.7% |
| FY2024 | $54.8M | -6.8% |
| FY2023 | $58.8M | -59.2% |
| FY2022 | $144.3M | +42.5% |
| FY2021 | $101.3M | +37.9% |
| FY2020 | $73.4M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026